The Medical, Legal, and Regulatory (MLR) review process is critical for ensuring compliance and accuracy in pharmaceutical and healthcare communications—but it’s often time-consuming and resource-intensive.
On today’s MAPS “Elevate” episode, we’ll discuss how Medical Affairs leaders present experiences from the design and implementation of impact frameworks
Medical Affairs teams produce more content than HCPs can consume. This article by Costello Medical explores how to cut content waste through insight-led planning, modular design, smart omnichannel personalisation, and impact-focused measurement — translating efficiency into better scientific exchange and patient outcomes.”
How Medical Affairs teams can break free from insights bottlenecks using AI — moving from reactive reporting to proactive, curiosity-driven strategic intelligence.
As the demand for increased levels of evidence grows, so too has the role of Non-Company Sponsored Research (NCSR). This position paper by the MAPS Evidence Generation Domain provides key considerations to ensure NCSR delivers strategic value.
On today’s MAPS “Elevate” episode, we’ll also discuss governance essentials, and a logical roadmap for responsible adoption, giving attendees the clarity and confidence needed to begin their own AI-enabled transformation.
Health misinformation is a critical threat to global public health. This podcast draws on early insights from an ongoing pilot in Sub-Saharan Africa to identify trusted DOLs we can partner with to design effective health education and advocacy programs.
Many Medical Affairs professionals lack holistic understanding of the business context in which medicines are developed or even view commercial aspects as incompatible with scientific and medical values. This paper provides fundamental understanding of business priorities, empowering Medical Affairs to contribute effectively to enterprise-wide
On today’s MAPS “Elevate” episode, we’ll deep dive into how Medical Affairs professionals can strengthen their business knowledge, expand their influence across organizations, and position themselves for executive leadership.
A white paper examining the “listening gap” in medical affairs and outlining how biopharma companies can use AI, process standardization, and cross-functional accountability to turn medical insights into measurable impact.